Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

7.7%

1 terminated out of 13 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed with results

Key Signals

1 with results83% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (7)
P 1 (1)
P 2 (1)
P 4 (1)

Trial Status

Completed5
Recruiting4
Unknown2
Terminated1
Not Yet Recruiting1

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (13)

Research Network

Activity Timeline